Seroba Life Sciences logo

Seroba Life Sciences

Crunchbase
Pitchbook
Crunchbase

Deals on record

5

Common Fundraising Type

Series B

Perfuze logo
Perfuze

Medical devices • Catheters

SV Health logo
Seroba logo
EQT Life Sciences logo
Earlybird logo

Perfuze is a medical device company that develops catheters designed to improve stroke treatment by enhancing the trackability and delivery of aspiration catheters.

Equity
$23.9M
03/13/2025
Article
Coave Therapeutics logo
Coave Therapeutics

Genetic medicines • ALIGATER™ platform

UI Investissement logo
Turenne Capital logo
Seroba Life Sciences logo
Omnes Capital logo

Coave Therapeutics develops genetic medicines using their ALIGATER™ platform to enhance treatment for CNS, neuromuscular, and eye diseases.

Series A
$33M
01/09/2025
Article
Deciphex logo
Deciphex

AI • Digital pathology

Molten Ventures logo
Seroba logo
Nextsteps Capital logo
IRRUS Investments logo

Deciphex is an AI-powered digital pathology company that enhances diagnostic efficiency and accuracy for pathologists.

Series C
$32.3M
01/07/2025
Article
ShiraTronics logo
ShiraTronics

Medical device • Neuromodulation

Norwest Venture Partners logo
U.S. Venture Partners logo
Treo Ventures logo
Seroba logo

ShiraTronics develops a neuromodulation device for treating chronic migraine patients.

Series B
$66M
10/09/2024
Article
Shorla Oncology logo
Shorla Oncology

Pharmaceutical • Oncology

Seroba Life Sciences logo
Kurma Partners logo
Enterprise Ireland logo

Shorla Oncology is a pharmaceutical company that develops oncology drugs for orphan and pediatric cancers, with a focus on addressing drug shortages and improving the preparation and application of oncology medication.

Series B
$35M
10/04/2023
Article